EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Colchicine in Coronary Artery Disease—Too Much of a Good Thing?

Hui Zhen Lo iD, Sanjay Patel, Jamie Layland

Journal of Cardiovascular Development and Disease · 22.06.2026 · 13 (6) · 284

DOI: 10.3390/jcdd13060284 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 22.06.2026. Verfasst von Hui Zhen Lo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bayside Health (Peninsula), Frankston, VIC 3199, Australia. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery disease (CAD) is the leading cause of mortality and morbidity in the world. While low-density lipoprotein cholesterol has been the main target of secondary prevention, inflammation has gained traction as a potential target for reducing adverse cardiovascular events. Hence, in this review, we aim to outline the current evidence base for the use of colchicine in CAD to provide more clarity from the findings in the recent trials and meta-analyses (LoDoCo2, COLCOT, COPS, CONVINCE, CLEAR-SYNERGY, COLOCT, and EKSTROM). Given colchicine’s low cost and widespread availability, it is a potential adjunct to lipid-lowering therapy. However, it may not be as effective in the secondary prevention of CAD as previously thought. Ongoing research on colchicine remains vital to determine its utility in patient populations beyond those with CAD as well as to better understand the fine balance between its therapeutic benefits and potential side effects.

Schlagwörter

Stichwörter der Autor:innen

colchicinecoronary artery disease

Autor:innen und Institutionen

  • Bayside Health (Peninsula), Frankston, VIC 3199, Australia.
  • Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
  • Coronary Diseases Group, Heart Research Institute, Newtown, NSW 2042, Australia.
  • Department of Cardiology, Bayside Health (Peninsula), Frankston, VIC 3199, Australia.
  • Department of Medicine, Peninsula Clinical School, Monash University, Frankston, VIC 3199, Australia.

ORCID-Profile: Hui Zhen Lo

Zitieren

APA

Lo, H. Z., Patel, S., & Layland, J. (2026). Colchicine in Coronary Artery Disease—Too Much of a Good Thing?. Journal of Cardiovascular Development and Disease, 13(6), 284. https://doi.org/10.3390/jcdd13060284

Vancouver

Lo HZ, Patel S, Layland J. Colchicine in Coronary Artery Disease—Too Much of a Good Thing?. Journal of Cardiovascular Development and Disease. 2026;13(6):284. doi:10.3390/jcdd13060284

BibTeX
@article{Lo2026,
  author = {Lo, Hui Zhen and Patel, Sanjay and Layland, Jamie},
  title = {Colchicine in Coronary Artery Disease—Too Much of a Good Thing?},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {284},
  doi = {10.3390/jcdd13060284}
}
Kostenlos starten →